A Review On The Synthetic Methodologies And Therapeutic Significance Of 3,4-Dihydropyrimidinones
DOI:
https://doi.org/10.63682/jns.v14i19S.4696Keywords:
3,4-Dihydropyrimidinones, DHPMs, anti-inflammatory, antioxidant, anticancer, catalysts, green synthesisAbstract
3,4-Dihydropyrimidinones are the most important heterocyclic compounds that are significant in the synthesis of nucleic acids. Dihydropyrimidinones have been produced by multi-component processes like the Biginelli reaction and the Hantzschdihydropyridine reaction.Due to extreme pharmacological action of dihydropyrimidinones, Biginelli reaction has been focused and derivatives are synthesized from past decades utilizing various catalysts and solvents to enhance more yield and decrease reaction time and to better pharmacological properties. In this review, we emphasize current advancements in this area, highlighting the recently developed DHPMs having better anti-inflammatory, antibacterial, antioxidant, antifungal, anticancer activities than the present standards
Downloads
Metrics
References
Abdul Lathiff MKM, Suresh R, Senthamarai R, SivakumarAnnadurai, Richie R. Bhandare, Afzal B. Shaik. 2024. Exploring substituted 3,4-dihydropyrimidinone and thionederivatives as anti-prostate cancer agents: Computational screening, synthesis, characterization, and in vitro efficacy assessment, 28(1): 101798 https://doi.org/10.1016/j.jscs.2023.101798
Babaei E, Mirjalili BBF.2019. One Pot Aqueous Media Synthesis of 1,3-Oxazine Derivatives Catalyzed by Reusable NanoAl2O3/BF3/Fe3O4 at Room Temperature. Polycyclic Aromatic Compounds.: 1-8 https://doi.org/10.1080/10406638.2019.1600561
Beller M, Zapf A 2002 in Handbook of Organopalladium Chemistry for Organic Synthesis, Vol. 1 (Eds.: ), Wiley, New York, 1209–1222
Bhosl MR, Deshmukh AR, Pal S, Srivastava AK, Mane RA, 2015. Synthesis of new thiazolylmethoxyphenylpyrimidines and antihyperglycemic evaluation of the pyrimidines, analogues isoxazolines and pyrazolines, Bioorg. Med. Chem. Lett. 25 2442-2446. DOI: 10.1016/j.bmcl.2015.03.068
deFátima Â, Braga TC, Neto L, da S, Terra BS, Oliveira BGF, et al. 2015.A mini-review on Biginelli adducts with notable pharmacological properties. Journal of Advanced Research. 6:363–373. doi: 10.1016/j.jare.2014.10.006
Dragovich PS, Fauber BP, Corson LB, Ding CZ, Eigenbrot CH, Giannetti AM, Hunsaker T, Labadie S, Liu Y, 2013. Identification of substituted 2- thio-6-oxo-1, 6-dihydropyrimidines as inhibitors of human lactate dehydrogenase, Bioorg. Med. Chem. Lett. 23 3186-3194. DOI: 10.1016/j.bmcl.2013.04.001
Gasperi T, Orsini M, Vetica F, Figueiredo R. 2015. Multicomponent Reactions: Concepts and Applications for Design and Synthesis. First edition. John Wiley & Sons; Organocatalytic asymmetric multicomponent reactions. https://doi.org/10.1002/9781118863992.
George N, Manakkadan AA, Ariyath A, Maniyamma S, Vijayakumar V, Pai RG, Zachariah SM. 2019 Chemistry and Pharmacological Activities of Biginelli Product-A Brief Overview. Current drug discovery technologies; 16(2):127-34 DOI: 10.2174/1570163815666180807141922
Graebin C, Ribeiro F, Rogério K, Kümmerle A. 2019.Multicomponent Reactions for the Synthesis of Bioactive Compounds: A Review. Current Organic Synthesis ;16:855–899. DOI: 10.2174/1570179416666190718153703
Joshi, RR, Barchha, A, Khedkar VM, Pissurlenkar RRS, Sarkar S, Sarkar, D,Joshi RR, Joshi RA, Shah AK, Coutinho EC. 2015. Targeting dormant tuberculosis bacilli: Results for molecules with a novel pyrimidone scaffold. Chem. Biol. Drug Des. 85, 201–207.
Kappe CO, 2000 Biologically active dihydropyrimidones of the Biginelli-type—a literature survey. European Journal of Medicinal Chemistry, 35(12), 1043-1052 https://doi.org/10.1016/S0223-5234(00)01189-2
Kaur R, Chaudhary S, Kumar K, Gupta MK, Rawal RK. 2017. Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review. European Journal of Medicinal Chemistry. 132:108–134. DOI: 10.1016/j.ejmech.2017.03.025
Kaur, Hardeep, Balasubramanian Narasimhan 2016. "Recent advances in the chemistry and biology of 3,4-dihydropyrimidin-2SSS (1H)-ones." RSC Advances 6.21: 16978-16994.
Kumar, Achutha Dileep; Prabhudeva, Gurumurthy M, Bharath, Srinivasan Kumara, Karthik; Lokanath, Krishnappagowda N; Kumar, AjayK. 2018."Design and Amberlyst-15 mediated synthesis of novel thienyl-pyrazolecarboxamides that potently inhibit Phospholipase A2 by binding to an allosteric site on the enzyme". Bioorganic Chemistry. Oct; (6) : 444-452 doi: 10.1016/j.bioorg.2018.06.023
Kumar, Pawan, and Manoj K. Mishra. 2017. "3,4-dihydropyrimidin-2 (1H)-ones: a class of versatile compounds with diverse pharmacological activities." Mini reviews in medicinal chemistry 17.10 : 879-905.
Lauro G, Strocchia M, Terracciano S, Bruno I, Fischer K, Pergola C, Werz O, Riccio R, Bifulco G 2014. Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E2 synthase-1 enzyme (mPGES-1), Eur. J. Med. Chem. 80 407-415. DOI: 10.1016/j.ejmech.2014.04.061
Liu Y, Liu J, Zhang R, Guo Y, Wang H, Meng Q, Sun Y, Liu Z.2019. Synthesis, Characterization, and Anticancer Activities Evaluation of Compounds Derived from 3, 4-Dihydropyrimidin-2 (1H)-one. Molecules. Jan;24(5):891 https://doi.org/10.3390/molecules24050891
Maleki A, Jafari AA, Yousefi S. 2017 MgFe2O4/cellulose/SO3H nanocomposite: a new biopolymer-based nanocatalyst for one-pot multicomponent syntheses of polysubstitutedtetrahydropyridines and dihydropyrimidinones. Journal of the Iranian Chemical Society.;14(8):1801-13 https://doi.org/10.1007/s13738-017-1120-2
Malik M, Seddigi Z, Bajee S, Azeeza S, Riyaz S, et al. 2019.Multicomponent access to novel proline/cyclized cysteine tethered monastrol conjugates as potential anticancer agents. Journal of Saudi Chemical Society.23:503–513. https://doi.org/10.1016/j.jscs.2019.01.003
Mathapati SR, Swami MB, Jadhav AH, Ghule NV, Dawle JK. 2017.ISSN 0975-413X CODEN (USA): PCHHAX Synthesis and antibacterial activity study of some new 1,3,4-thiadiazole derivatives, 9(6):1-5 DOI:10.13140/RG.2.2.34180.63362
Matos L, Masson F, Simeoni L, Homem-de-mello M. 2018.Biological activity of dihydropyrimidinone (DHPM) derivatives: A systematic review. European Journal of Medicinal Chemistry. 143:1779–1789. DOI: 10.1016/j.ejmech.2017.10.073
Mats Larhed and Anders HallbergThe Journal of Organic Chemistry 1996 61 (26), 9582-9584
McNaughton BR & Miller BL, 2006 Design strategies for the treatment of Alzheimer's disease. Current Opinion in Chemical Biology,10(5), 432-439.
Nagarajaiah H, Mukhopadhyay A, Moorthy JN. 2016. Biginelli reaction: an overview. Tetrahedron Letters. 57:5135–5149 https://doi.org/10.1016/j.tetlet.2016.09.047
Naidu BN, Sorenson ME, Patel M, Ueda Y, Banville J, Beaulieu F, Bollini S, Dicker IB, Higley H, Lin Z, 2015. Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors, Bioorg. Med. Chem. Lett. 25 717-720. DOI:10.1016/j.bmcl.2014.11.060
Nassima Khaldi-Khellafi, Malika Makhloufi-Chebli, Djamila Oukacha-Hikem, SouhilaTerachet Bouaziz, Kamilia OuldLamara ,TaousIdir, Amina Benazzouz-Touami, Françoise Dumas, 2019. Green synthesis, antioxidant and antibacterial activities of 4-aryl-3,4- dihydropyrimidinones/thiones derivatives of curcumin. Theoretical calculations and mechanism study: Journal of Molecular Structure, 1181, 261-269. https://doi.org/10.1016/j.molstruc.2018.12.104
Nevagi R, Narkhede H. 2014. Novel dihydropyrimidine derivatives as antibacterial agents. Der PharmaChemica. 6:135–139.
Nielsen CF, Zhang T, Barisic M, Kalitsi P, Hudson DF,2020. Topoisomerase IIα is essential for maintenance of mitotic chromosome structure Proc. Natl. Acad. Sci. U.S.A.,117 (22): 12131-12142 . doi: 10.1073/pnas.2001760117
Saha, Debanjan, and Pradeep K. Maity. 2014. "Copper-catalyzed cascade reaction for the synthesis of 3,4-dihydropyrimidin-2 (1H)-ones." Organic letters 16.15; 4066-4069.
Sanapalli BKR, Ashames A, Sigalapalli DK, Shaik AB, Bhandare RR, Yele V. 2022. Synthetic imidazopyridine-based derivatives as potential inhibitors against multi-drug resistant bacterial infections: a review Antibiotics, 11: 1680 https://doi.org/10.3390/antibiotics11121680
Singh K, Singh K.2012. Biginelli Condensation: Synthesis and Structure Diversification of 3,4-Dihydropyrimidin-2(1H)-one Derivatives, Advances in Heterocyclic Chemistry. Elsevier Inc; pp. 223–308 https://doi.org/10.1016/B978-0-12-396530-1.00003-6
Soni R, Singh G, Kaur R, Kaur G, Gill RK, Bariwal J, 2014. Review on Monastrol: A Novel Kinesin-5 Inhibitor, Chemistry & biology interface, Chem. Biol. 4 163-175.
Song, Lin-Jian, et al. 2017. "Recent advances in palladium-catalyzed cross-coupling reactions for the synthesis of 3,4-dihydropyrimidin-2 (1H)-ones." Organic Chemistry Frontiers 4.2 : 195-219.
Trivedi, Anjali R., and Vinayak D. Pol. 2017."Recent advances in transition metal-catalyzed synthesis of 3,4-dihydropyrimidin-2 (1H)-ones." RSC Advances 7.27 16156-16175.
Trivedi HD, Joshi VB,Patel BY. 2022. Pyrazole Bearing Pyrimidine Analogues as the Privileged Scaffolds in Antimicrobial Drug Discovery: A Review Anal. Chem. Lett.,12: 147-173 DOI:10.4067/S0717-97072020000104746
Yadlapalli RK,Chourasia OP, Vemuri K, Sritharan M, Perali RS. 2012. Synthesis and in vitro anticancer and antitubercular activity of diarylpyrazole ligated dihydropyrimidines possessing
Yazdan SK, Sagar DV, Shaik AB, 2015. Synthesis, characterization and biological evaluation of some new pyrimidine derivatives as anti-inflammatory and cytotoxic agents Res. J. Pharmaceut. Biol. Chem. Sci.,173-185
Zheng Y, Jiang Y, 2015 mTOR inhibitors at a Glance, Mol. Cell. Pharmacol. 7 15-20.
Zhu J, Wang Q. 2015. Multicomponent Reactions in Organic Synthesis. First Edition. Wiley-VCHVerlag GmbH & Co. KGaA
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
